P 390 5 Apr 358.20 380 370 360 350 28
P 5
The share price of Nasdaq-listed Achilles Therapeutics, a portfolio company of
(c) 2024 City A.M., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
464 GBX | -0.85% | -2.15% | -0.13% |
05-09 | NatWest target raised, other lenders backed | AN |
05-08 | OSB hails first-quarter performance; set to meet guidance | AN |
P 390 5 Apr 358.20 380 370 360 350 28
P 5
The share price of Nasdaq-listed Achilles Therapeutics, a portfolio company of
(c) 2024 City A.M., source
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
464 GBX | -0.85% | -2.15% | 2.32B | ||
144 GBX | +4.73% | +7.06% | 225M | ||
110.6 GBX | -0.36% | -.--% | 914M | ||
1st Jan change | Capi. | |
---|---|---|
-0.13% | 2.32B | |
-12.60% | 81.16B | |
-11.58% | 19.35B | |
+5.11% | 13.11B | |
+43.93% | 8.9B | |
-8.88% | 6.57B | |
+2.58% | 4.62B | |
+18.02% | 4.17B | |
-13.53% | 3.24B | |
-17.32% | 2.68B |